Journal of Lipid Research, Vol 38, 2492-2501, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin

I Murray, RA Parker, TG Kirchgessner, J Tran, ZJ Zhang, J Westerlund and K Cianflone
Mike Rosenbloom Laboratory for Cardiovascular Research, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.

Acylation stimulating protein (ASP) acts upon adipose tissue to stimulate triglyceride synthesis and glucose transport. The aim of the present study was to produce recombinant ASP and to measure its bioactivity. The cDNA region of the parent complement C3 sequence coding for ASP (C3adesArg) was cloned and expressed in E. coli. Bioactivity of the purified recombinant material was tested by determining its effect on triglyceride synthesis, glucose transport, and competition binding assays. In standard assays, concentrations of 5.5 microM recombinant ASP (rASP) stimulated triglyceride synthesis comparably to plasma ASP (pASP): 228% versus 237%, respectively, in 3T3 preadipocytes and 568% versus 440% in human differentiated adipocytes. rASP also increased glucose transport in L6 myocytes (163% at 10 microm rASP) and in human differentiated adipocytes (334% rASP vs. 329% pASP at 5 microM). rASP competitively displaced radiolabeled plasma ASP from high affinity association with the cell surface in both human differentiated adipocytes and 3T3 preadipocyte fibroblasts. Furthermore, immunoprecipitation of rASP and pASP with a specific monoclonal antibody abolished stimulation of cellular triglyceride synthesis. Lastly, we contrasted the structure:function activities of the arginated (C3a) and desarginated (ASP) proteins. The lipogenic activity and the anaphylatoxic activity result from distinct structural domains of the polypeptides. Thus rASP retains full biologic ASP activity and may provide a tool to study structure-function relationships in this physiologic system.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Marcil, H. Vu, W. Cui, Z. Dastani, J. C. Engert, D. Gaudet, M. Castro-Cabezas, A. D. Sniderman, J. Genest Jr, and K. Cianflone Identification of a Novel C5L2 Variant (S323I) in a French Canadian Family With Familial Combined Hyperlipemia Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1619 - 1625. [Abstract] [Full Text] [PDF]

				D. Kalant, R. MacLaren, W. Cui, R. Samanta, P. N. Monk, S. A. Laporte, and K. Cianflone C5L2 Is a Functional Receptor for Acylation-stimulating Protein J. Biol. Chem., June 24, 2005; 280(25): 23936 - 23944. [Abstract] [Full Text] [PDF]

				L. Persson, J. Boren, A.-K. L. Robertson, V. Wallenius, G. K. Hansson, and M. Pekna Lack of Complement Factor C3, but Not Factor B, Increases Hyperlipidemia and Atherosclerosis in Apolipoprotein E-/- Low-Density Lipoprotein Receptor-/- Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1062 - 1067. [Abstract] [Full Text] [PDF]

				Z. Xia, K. L. Stanhope, E. Digitale, O.-M. Simion, L. Chen, P. Havel, and K. Cianflone Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice J. Biol. Chem., February 6, 2004; 279(6): 4051 - 4057. [Abstract] [Full Text] [PDF]

				D. Kalant, S. A. Cain, M. Maslowska, A. D Sniderman, K. Cianflone, and P. N. Monk The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein J. Biol. Chem., March 21, 2003; 278(13): 11123 - 11129. [Abstract] [Full Text] [PDF]

				Z. Xia, A. D. Sniderman, and K. Cianflone Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice J. Biol. Chem., November 22, 2002; 277(48): 45874 - 45879. [Abstract] [Full Text] [PDF]

				I. Kratchmarova, D. E. Kalume, B. Blagoev, P. E. Scherer, A. V. Podtelejnikov, H. Molina, P. E. Bickel, J. S. Andersen, M. M. Fernandez, J. Bunkenborg, et al. A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes Mol. Cell. Proteomics, March 1, 2002; 1(3): 213 - 222. [Abstract] [Full Text] [PDF]

				I. Murray, P. J. Havel, A. D. Sniderman, and K. Cianflone Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein Endocrinology, March 1, 2000; 141(3): 1041 - 1049. [Abstract] [Full Text] [PDF]

				I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice J. Biol. Chem., December 17, 1999; 274(51): 36219 - 36225. [Abstract] [Full Text] [PDF]

				I. Murray, A. D. Sniderman, and K. Cianflone Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance J. Lipid Res., September 1, 1999; 40(9): 1671 - 1676. [Abstract] [Full Text]

				I. Murray, A. D. Sniderman, and K. Cianflone Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E474 - E480. [Abstract] [Full Text] [PDF]

				R. A. Wetsel, J. Kildsgaard, E. Zsigmond, W. Liao, and L. Chan Genetic Deficiency of Acylation Stimulating Protein (ASP(C3ades-Arg)) Does Not Cause Hyperapobetalipoproteinemia in Mice J. Biol. Chem., July 2, 1999; 274(27): 19429 - 19433. [Abstract] [Full Text] [PDF]

				J. Saleh, N. Christou, and K. Cianflone Regional specificity of ASP binding in human adipose tissue Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E815 - E821. [Abstract] [Full Text] [PDF]